We are monitoring the impact of COVID-19 on Clinical Data Analytics Market Get in touch with us for detailed analysis Know More
Pulished Date February, 2020
ID: 1671
Share on
Share on

Global Clinical Data Analytics Market Analysis – By Deployment Model (Cloud, On Premise), End User(Pharmaceuticals, Healthcare Providers, Biotechnology, Academia), Region - Industry Size, Share, Trends, Growth, Forecast | 2019 - 2024

Pulished: February, 2020
ID: 1671
Pages: 172

CLINICAL DATA ANALYTICS MARKET

Industry Overview

As per our reports, the size of the clinical data analytics market was worth USD 8.0 billion in 2020 and is projected to grow with CAGR of 44.79% to reach USD 50.7 billion by 2025 during the forecast framework.

The doctors, physicians and surgeons take help from clinical data analytics while making decisions concerning about the patient care and assists in a better way to understand the healthiness of the population.

Drivers

Increasing research and development activities, advancing the quality of healthcare, new advance technologies like mhealth, and IoT propel the growth during the forecast period. Increasing frequency of cardiac diseases among the clinical data analytics market, quick emerging countries due to changes in regulatory framework surge the market growth over the analysis period.

Restrains

Factors like shortage of IT skilled professionals in healthcare, cost of the treatment is so expensive which is considered to hamper the clinical data analytics market growth globally.Lack of awareness among the professionals, surgeons in how to make use of the clinical data analytics for the sake of patient’s healthcare.

Recent Market Developments

  • On July 23, 2020, Cerner Corporation ad Holon Solutions have partnered together in providing progressive clinical decision support technology for upgrading patient outcomes and both the companies will employ patented technology which will bring administered patient specific knowledge straight away into provider workflows in advancing the reimbursements and results.
  • On November 22, 2019, Intersystem and Virtusa both partner together to in providing the access to patient data from EHR and other clinical applications.
  • On January 03, 2016, Caradigm has launched an open exchange for healthcare interoperability potentiality which uses (CIP) Caradigm Intelligence Platform which uses this CIP to build data assets which supports number of potentialities.

REPORT COVERAGE

REPORT METRIC

DETAILS

Market Size Available

2019 – 2025

Base Year

2019

Forecast Period

2020 - 2025

Segments Covered

By Deployment Model, End-user, Region

Various Analyses Covered

Global, Regional & Country Level Analysis, Segment-Level Analysis, DROC, PESTLE Analysis, Porter’s Five Forces Analysis, Competitive Landscape, Analyst Overview on Investment Opportunities

Regions Covered

North America, Europe, APAC, Latin America, Middle East & Africa

Market Leaders Profiled

IBM, CareEvolution, Intersystems, Explorys, Cerner, Caradigm, Truven Health Analytics, Wellcentive, McKesson, Athenahealth.

 

This market research report on Global Clinical Data Analytics Market has been segmented and sub-segmented into the following categories and analyzed market size and forecast until 2024.

Clinical Data Analytics Market Analysis – By Type

  • Prescriptive
  • Descriptive
  • Predictive

Based on the type analysis, descriptive segment is anticipated to account for the highest share in the clinical data analytics market as applications in process optimization among the organizations.The potentiality of descriptive analytics to analyze historical data and gain actionable future insights which help in growth of the segment.

Prescriptive analytics segment is expected to witness CAGR of 15.8% during the forecast period as implications on key business metrics, capability to expect regarding the possible outcomes.

Clinical Data Analytics Market Analysis – By Component

  • Software
  • Hardware
  • Services

Based on the component analysis, hardware segment is dominating the clinical data analytics market growth during the analysis period.

Clinical Data Analytics Market Analysis – By Delivery Mode

  • On-Premise
  • Web-based
  • Cloud-based

Based on the delivery mode analysis, the on-premise segment is anticipated to dominate the market which accounts for 54.0% of the share globally during the forecast period which owes to simple configurable nature of this segment solution when compared to on-demand models.

Clinical Data Analytics Market Analysis – By Application

  • Clinical
  • Financial
  • Operational and Administrative

Based on the application analysis, the financial segment is anticipated to grow with highest CAGR as of increasing applications of analytics to reduce the growing healthcare price and also offers quality patient care, extensive usage of analytics to determine and prevent healthcare deceit which will increase the demand further.

Clinical segment is expected to have strong growth where it allows lessening the amount spent on healthcare, offering quality patient care attributing for important industry care.

Clinical Data Analytics Market Analysis – By End-User

  • Health Payers
  • Healthcare Providers
  • Others

Based on the end-user analysis, the health payers segment has got an important share in the clinical data analytics market over the analysis period as increase in healthcare cost, increasing requirement for rising memberships, decrease the fraud claims, which bolster the market growth during the analysis period.

Regional Analysis

North America Clinical Data Analytics Market  is dominating the market globally. The clinical data analytics market in this region has got largest share as a result of upgraded healthcare infrastructure, increasing per capita spent on healthcare, growing regulatory needs, reduce the growing healthcare price in this region. US market is expected to lead the market due to presence of well-established healthcare infrastructure, approval of advance technologies, and obtainment ofEHR. Canada is followed next to US.

Europe Clinical Data Analytics Market is projected to account for the second largest share in the clinical data analytics market over the analysis period as there is an increase in research and development activities, growing funds for healthcare which boost the market growth.

Asia-Pacific Clinical Data Analytics Market is considered to be the quickest growing in the clinical data analytics market due to increasing aging population, changes in healthcare domain with in short span of time, increasing economic growth and advancing healthcare amenities. China and India are the two leading markets of this region with huge unsatisfied needs. Japan is expected to have major share in the market with CAGR of 11.8% over the analysis period as existence of advanced healthcare IT infrastructure and growing initiatives in reducing growing medical costs

Latin America Clinical Data Analytics Market is expected to have fixed and continuous growth during the period due to advance technologies, cost supportive and favorable government reimbursement policies.

Middle East & Africa Clinical Data Analytics Market is anticipated to have steady growth rate during the review period in the clinical data analytics market globally. The growth owes to growing funds and investments in research and development, well-developed infrastructure and technological advancements in this region.

Companies leading the Global Clinical Data Analytics Market profiled in the report are:

  1. IBM
  2. CareEvolution
  3. Caradigm
  4. Explorys
  5. Cerner
  6. Intersystems
  7. Athenahealth
  8. Truven Health Analytics
  9. Wellcentive
  10. McKesson

1.Introduction            

                1.1 Market Definition                    

                1.2 Study Deliverables                  

                1.3 Base Currency, Base Year and Forecast Periods    

                1.4 General Study Assumptions                

2. Research Methodology                     

                2.1 Introduction         

                2.2 Research Phases

          2.2.1 Secondary Research           

          2.2.2 Primary Research 

          2.2.3 Econometric Modelling      

          2.2.4 Expert Validation  

                2.3 Analysis Design   

                2.4 Study Timeline    

3. Overview                 

                3.1 Executive Summary                

                3.2 Key Inferences   

                3.3 Epidemology        

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)              

                4.1 Market Drivers    

                4.2 Market Restraints                    

                4.3 Key Challenges   

                4.4 Current Opportunities in the Market        

5. Market Segmentation  

                5.1 Deployment Model                

          5.1.1 Introduction           

          5.1.2 Cloud         

          5.1.3 On-Premise            

          5.1.4  Y-o-Y Growth Analysis, By Deployment Model       

          5.1.5  Market Attractiveness Analysis, By Deployment Model     

          5.1.6  Market Share Analysis, By Deployment Model      

                 5.2 Services 

          5.2.1 Introduction           

          5.2.2 Consulting               

          5.2.3 Maintenance         

          5.2.4 Y-o-Y Growth Analysis, By Services               

          5.2.5 Market Attractiveness Analysis, By Services             

          5.2.6 Market Share Analysis, By Services              

                5.3 End-User  

          5.3.1 Introduction           

          5.3.2 Pharmaceuticals   

          5.3.3 Healthcare Providers          

          5.3.4 Biotechnology       

          5.3.5 Academia

          5.3.6 Y-o-Y Growth Analysis, By End-User

          5.3.7  Market Attractiveness Analysis, By End User             

          5.3.8  Market Share Analysis, By End User             

6. Geographical Analysis  

                6.1 Introduction         

          6.1.1 Regional Trends    

          6.1.2 Impact Analysis     

          6.1.3 Y-o-Y Growth Analysis        

    6.1.3.1 By Geographical Area

    6.1.3.2 By Deployment Model

    6.1.3.3 By Services

    6.1.3.4 By End Use Sector

                6.1.4  Market Attractiveness Analysis     

    6.1.4.1 By Geographical Area

    6.1.4.2 By Deployment Model

    6.1.4.3 By Services

    6.1.4.4 By End-User

                      6.1.5  Market Share Analysis      

    6.1.5.1 By Geographical Area

    6.1.5.2 By Deployment Model

    6.1.5.3 By Services

    6.1.5.4 By End-User

                6.2 North America    

          6.2.1 Introduction           

          6.2.2 United States         

          6.2.3 Canada     

              6.3 Europe   

          6.3.1 Introduction           

          6.3.2 U.K             

          6.3.3 Spain         

          6.3.4 Germany 

          6.3.5 Italy            

          6.3.6 France       

            6.4 Asia-Pacific                 

          6.4.1 Introduction           

          6.4.2 China         

          6.4.3 India          

          6.4.4 Japan         

          6.4.5 Australia   

          6.4.6 South Korea           

                6.5 Latin America       

          6.5.1 Introduction           

          6.5.2 Brazil          

          6.5.3 Argentina

          6.5.4 Mexico     

          6.5.5 Rest of Latin America          

                6.6 Middle East & Africa               

          6.6.1 Introduction           

          6.6.2 Middle-East            

          6.6.3 Africa         

7.Strategic Analysis                  

                7.1 PESTLE analysis   

          7.1.1 Political     

          7.1.2 Economic 

          7.1.3 Social         

          7.1.4 Technological         

          7.1.5 Legal          

          7.1.6 Environmental       

                7.2 Porter’s Five analysis        

          7.2.1 Bargaining Power of Suppliers        

          7.2.2 Bargaining Power of Consumers    

          7.2.3 Threat of New Entrants     

          7.2.4 Threat of Substitute Products and Services              

          7.2.5 Competitive Rivalry within the Industry     

8.Market Leaders' Analysis                   

                 8.1 IBM                

          8.1.1 Overview 

          8.1.2 Product Analysis   

          8.1.3 Financial analysis  

          8.1.4 Recent Developments       

          8.1.5 SWOT analysis       

          8.1.6 Analyst View          

                8.2 CareEvolution      

                8.3 Cardigm 

                8.4 Explorys 

                8.5 Cerner    

                8.6 Intersystems       

                8.7 Athenahealth      

                8.8 Truven Health Analytics  

                8.9 Wellcentive                

                8.10 McKesson                 

9.Competitive Landscape

                9.1 Market share analysis      

                9.2 Merger and Acquisition Analysis 

                9.3 Agreements, Collaborations, and Joint Ventures   

                9.4 New Product Launches   

10.Market Outlook and Investment Opportunities                    

Appendix                     

                a) List of Tables                

                b) List of Figures        

  • Global, regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market

Request Sample Brochure to View

Please wait. . . . Your request is being processed

LICENCE TYPE

$ 1234 4255

Clients
clients
clients
clients
clients
clients
clients
Click for Request Sample